Investigations on changes in 13C/12C ratios of endogenous urinary steroids after pregnenolone administration

Drug Testing and Analysis

Volumn 3, Issue 5, 2011, Pages 283-290

  Piper, Thomas ^a   Schlug, Christoph ^a   Mareck, Ute ^a   Schänzer, Wilhelm ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Carbon isotope ratio; Doping control; Excretion study; Pregnenolone; Steroid metabolism

Indexed keywords

ISOTOPES; LIPIDS; MASS SPECTROMETRY; SPECTROMETERS;

CARBON ISOTOPE RATIO; DOPING CONTROL; EXCRETION STUDY; ISOTOPE-RATIO MASS SPECTROMETRY; NATURALLY OCCURRING; PREGNENOLONE; REFERENCE COMPOUNDS; STEROID METABOLISM; TARGET ANALYTES; TESTOSTERONE;

CARBON;

BIOVEA; CARBON; CARBON 13; PREGNENOLONE; TESTOSTERONE; UNCLASSIFIED DRUG; ANABOLIC AGENT; GLUCURONIDE; PREGNANEDIOL; SULFATE;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG CONCENTRATION; DRUG DOSE COMPARISON; DRUG TARGETING; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; STEROID URINE LEVEL; URINARY EXCRETION; CHEMISTRY; DOPING; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; ORAL DRUG ADMINISTRATION; STANDARD; SUBSTANCE ABUSE; URINE;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; ANABOLIC AGENTS; CARBON ISOTOPES; DOPING IN SPORTS; GLUCURONIDES; HUMANS; MALE; MASS SPECTROMETRY; PREGNANEDIOL; PREGNENOLONE; REFERENCE STANDARDS; SUBSTANCE ABUSE DETECTION; SULFATES; TESTOSTERONE;

EID: 79956208106     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.281     Document Type: Article

References (37)

1. L. Träger. Steroidhormone. Springer Verlag: Berlin, 1977.
2. A. H. Payne, D. B. Hales. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr. Rev. 2004, 25, 947.
3. C. Meystre, H. Frey, R. Neher, A. Wettstein, K. Miescher. Gewinnung von 1, 4-bisdehydro-3-oxo-steroiden. Helv. Chim. Acta 1946, 29, 627.
4. J. P. P. Stock, E. C. McClure. Pregnenolone in the treatment of rheumatoid arthritis. Lancet 1950, 662, 125.
5. A receptor. Biochem. Pharmacol. 1995, 49, 1, and references therein.
6. M. S. Ritsner. Pregnenolone, dehydroepiandrosterone, and schizophrenia: Alterations and clinical trials. CNS Neurosci.Ther. 2010, 16, 32, and references therein.
7. World Anti-Doping Agency. The 2010 Prohibited List, International Standard. Available at: [26 July 2010].
8. M. Ferry, J. C. Mathurin, M. Becchi, J. de Ceaurriz, in Recent Advances in Doping Analysis (8), (Eds: W. Schänzer, H. Geyer, A. Gotzman, U. Mareck-Engelke), Sport&Buch Strauß: Cologne, 2000, pp. 209.
9. C. Saudan, N. Baume, P. Mangin, M. Saugy. Urinary analysis of 16(5α)-androsten-3α-ol by gas chromatography/combustion/isotope ratio mass spectrometry: Implications in anti-doping analysis. J. Chromatogr. B 2004, 810, 157.
10. C. Saudan, A. Desmarchelier, P. E. Sottas, P. Mangin, M. Saugy. Urinary marker of oral pregnenolone administration. Steroids 2005, 70, 179.
11. C. H. L. Shackleton, E. Roitman, A. Phillips, T. Chang. Confirming testosterone administration by isotope ratio mass spectrometry analysis of urinary androstenediols. Steroids 1997, 62, 379.
12. R. Aguilera, C. K. Hatton, D. H. Catlin. Detection of epitestosterone doping by isotope ratio mass spectrometry. Clin. Chem. 2002, 48, 629.
13. A. T. Cawley, R. Kazlauskas, G. J. Trout, J. H. Rogerson, A. V. George. Isotopic fractionation of endogenous anabolic androgenic steroids and its relationship to doping control in sports. J. Chrom. Sci. 2005, 43, 32.
14. 12C ratios of endogenous urinary steroids: method validation, reference population and application to doping control purposes. Rapid Commun. Mass Spec. 2008, 22, 2161.
15. H. Craig. Isotopic standards for carbon and oxygen and correction factors for mass-spectrometric analysis of carbon dioxide. Geochim. Cosmochim. Acta 1957, 12, 133.
16. 13C-Values of endogenous urinary steroids. Steroids 2008, 73, 408.
17. 12C ratios of urinary epitestosterone and its main metabolites 5α- and 5β-androstane-3α, 17α-diol. Drug Test. Analysis 2009, 1, 576.
18. 13C) values of urinary steroids for doping control in sport. Steroids 2009, 74, 379.
19. 12C ratios of endogenous urinary steroids excreted as sulpho-conjugates. Rapid Commun. Mass Spec. 2010, 24, 3171.
20. 35-sulfate in vivo: An example of the 'direct' metabolism of a steroid conjugate. Steroids 1963, 2, 429.
21. 35. Biochemistry 1963, 2, 648.
22. H. Geyer, U. Mareck-Engelke, U. Reinhart, M. Thevis, W. Schänzer. Positive doping cases with norandrosterone after application of contaminated nutritional supplements. Deut. Z. Sportmed. 2000, 51, 378.
23. U. Mareck, H. Geyer, G. Opfermann, M. Thevis, W. Schänzer. Factors influencing the steroid profile in doping control analysis. J. Mass Spectrom. 2008, 43, 877.
24. U. Flenker, M. Hebestreit, T. Piper, F. Hülsemann, W. Schänzer. Improved performance and maintenance in gas chromatography/isotope ratio mass spectrometry by precolumn solvent removal. Anal. Chem. 2007, 79, 4162.
25. 13C analysis of small polyfunctional compounds. Rapid Commun. Mass Spec. 2001, 15, 730.
26. C. D. Keeling. The concentration and isotopic abundance of atmospheric carbon dioxide in rural areas. Geochim. Cosmochim. Acta 1958, 13, 322.
27. D. E. Pataki, J. R. Ehlering, L. B. Flanagan, D. Yakir, D. R. Bowling, C. J. Still, N. Buchmann, J. O. Kaplan, J. A. Berry. The application and interpretation of Keeling plots in terrestrial carbon cycle research. Global Biogeochemical Cycles 2003, 17, 1022.
28. O. Jänne. Quantitative determination of neutral steroid mono- and disulphates in human urine. Clin. Chim. Acta 1970, 29, 529.
29. M. Axelson, B. L. Sahlberg, J. Sjövall. Analysis of profiles of conjugated steroids in urine by ion-exchange separation and gas chromatography-mass spectrometry. J. Chrom. 1981, 224, 355.
30. L. Dehennin, P. Lafarge, P. Dailly, D. Bailloux, J. P. Lafarge. Combined profile of androgen glucuro- and sulfoconjugates in post-competition urine of sportsmen: a simple screening procedure using gas chromatography-mass spectrometry. J. Chrom. B 1996, 687, 85.
31. C. von Kuk, U. Flenker, W. Schänzer. Recent Advances in Doping Analysis (11), (Eds: W. Schänzer, H. Geyer, A. Gotzman, U. Mareck), Sport&Buch Strauß: Cologne, 2003, pp. 169.
32. G. Michal. Biochemical Pathways, Spektrum Akademischer Verlag: Heidelberg, 1999.
33. P. Kremers. Progesterone and pregnenolone 17α-hydroxylase: Substrate specifity and selective inhibition by 17α-hydroxylated products. J. Steroid Biochem. 1976, 7, 571.
34. D.F Fan, H. Oshima, B. R. Troen, P. Troen. Studies of the human testis: IV. Testicular 20α-hydroxysteroid dehydrogenase and steroid 17α-hydroxylase. Biochem. Biophys. Acta 1974, 360, 88.
35. J.J.A.M. Weusten, A. G. H. Smals, J. A. Hofman, P. W. C. Kloppenborg, T. J. Benraad. The sex pheromone precursor androsta-5, 16-dien-3β-ol is a major early metabolite in in vitro pregnenolone metabolism in human testicular homogenates. J. Clin. Endoc. Metab. 1987, 65, 753.
36. J.J.A.M. Weusten, G. Legemaat, M.P.M.E. van der Wouw, A. G. H. Smals, P. W. C. Kloppenborg, T. J. Benraad. The mechanism of the synthesis of 16-androstenes in human testicular homogenates. J. Steroid Biochem. 1989, 32, 689.
37. R. J. Cenedella, J. A. Belis. Studies on the source of urinary cholesterol in the normal human male. J. Lipid Res. 1981, 22, 122.